FIELD: pharmacy. SUBSTANCE: natural polypeptide substances obtaining by extraction from animal tissue homogenates can induce antibody formation after their administration in animals of different species. These antibodies are able to recognize in vivo or in vitro antigens in human tumor cells, can decrease or suppress pain, cause lysis of cells and inhibit or delay tumor growth after their administration in human with malignant tumors of different type. EFFECT: enhanced effectiveness of polypeptides. 3 cl, 7 tbl, 12 dwg
| Title |
Year |
Author |
Number |
| GOAT FEMALE LIVER PROTEINS SHOWING ANTITUMOR ACTIVITY, PHARMACEUTICAL COMPOSITION |
1995 |
- Severino Ronchi
- Al'Berto Bartorelli
|
RU2163243C2 |
| ANTIBODIES AGAINST ALLOGENIC AND XENOGENIC PROTEINS, THEIR APPLICATION IN THERAPY AND MAKING DIAGNOSIS, METHOD FOR DETERMINING THEM |
1995 |
|
RU2160445C2 |
| APPLICATION OF PROTEINS AS ANTIRETROVIRAL AGENTS |
1997 |
- Bartorelli Al'Berto
- De G'Juli Morgen Karlo
|
RU2203071C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATING MALIGNANT NEOPLASM |
2018 |
- Yoshida Tetsuya
- Kidani Yujiro
- Matsumoto Mitsunobu
- Kanazawa Takayuki
- Shinonome Satomi
- Hojo Kanji
- Ohkura Naganari
- Sakaguchi Shimon
- Tanaka Atsushi
- Wada Hisashi
- Kawashima Atsunari
- Nonomura Norio
|
RU2730984C1 |
| COMBINED THERAPY FOR CANCER TREATMENT |
2015 |
- Bao, Xingfeng
- Albu, Diana
- Woodall-Jappe, Mary
|
RU2708374C2 |
| COMPOSITIONS CAUSING SPECIFIC RESPONSE OF CYTOTOXIC T-LYMPHOCYTES, INCLUDING LYMPH-ABLATIVE COMPOUND AND MOLECULE WHICH CONTAINS ANTIGEN SEQUENCES AND IS TARGETED AT SPECIALISED ANTIGEN-PRESENTING CELLS |
2007 |
- Previll' Ksav'E
- Timmerman Benedikt
|
RU2448729C2 |
| DUOCARMICIN ADC SHOWING IMPROVED ANTI-TUMOUR ACTIVITY IN VIVO |
2015 |
- Dokter Villem
- Besker Patrik Khenri
- Gudings Peter Jokhannes
- Verkhejden Gejsbertus Fransiskus Mariya
|
RU2689779C2 |
| DUOCARMYCIN ADCs EXHIBITING IMPROVED ANTI-TUMOUR ACTIVITY IN VIVO |
2015 |
- Dokter, Villem
- Gudings, Peter Jokhannes
- Verkhejden, Gejsbertus Fransiskus Mariya
- Besker, Patrik Khenri
|
RU2769700C2 |
| GM-CSF OR GM-CSF RECEPTOR LIGANDS FOR USE IN TREATMENT OF HEMOBLASTOSIS IN PATIENT WHO HAS UNDERGONE ALLO-HCT |
2019 |
- Tugues, Sonia
- Becher, Burkhard
|
RU2772132C2 |
| COMBINATION OF ANTI-EDb FIBRONECTIN ANTIBODY-IL-2 FUSION PROTEIN, AND MOLECULE BINDING TO B-CELLS, B-CELL PROGENITORS AND/OR THEIR CANCEROUS COUNTERPART |
2008 |
- Neri Dario
- Menssen Khans Ditrikh
- Menrad Andreas
- Shliman Kristof
|
RU2484845C2 |
